White House Monitoring Suspected Plague Case in Russia

White House Monitoring Suspected Plague Case in Russia

A Trump administration official told Axios that the White House is aware of the situation in Russia's Irkutsk region in Siberia.

"The administration is aware, monitoring the outbreak, and assessing options," the official said Sunday.

The case: Daria Shipilova, 28, a lab technician at the Irkutsk Anti-Plague Research Institute of Siberia and the Far East. The independent outlet Lyudi Baikala reported she broke a test tube containing plague bacteria on September 25, was hospitalized in Shelekhov on September 29 with severe pneumonia, and died overnight October 1 to 2. That account is unconfirmed.

What is confirmed and what isn't

Nearly 200 contacts were placed under medical observation or isolation, several medical facilities were quarantined, and mask requirements appeared in some workplaces. Governor Igor Kobzev said contacts showed no signs of illness and initial tests were negative.

Russia's health agency, Rospotrebnadzor, has not confirmed plague. It diagnosed pneumonia of unknown etiology, said expanded testing found no microorganisms linked to her work, found no lab accident in its review, and called the regional epidemiological situation stable.

Alexei Tsydenov, head of neighboring Buryatia, said the woman "died, maybe of the plague," while adding there were no plague outbreaks in Buryatia.

Separately, the State Department said it is aware of reports of "a fatal case of suspected pneumonic plague in Irkutsk Oblast" and is tracking the situation with the CDC and other agencies, urging Russian authorities "to share accurate information quickly and openly."

For context, the U.S. had a fatal pneumonic plague case in Arizona in 2025 with no secondary illnesses. Plague is bacterial and treatable with common antibiotics if caught quickly.


Do you want to see how to make more plays? Do you want to find gains yourself?

Unusual Whales helps you find market opportunities through our market tide, historical options flow, GEX, and much, much more.

Create a free account here to start conquering the market with Unusual Whales


Options market and stocks to watch

Same read as any outbreak headline: no direct market channel, but biotech names can see knee-jerk call buying before the news fades. Watch these names:

PFE: Pfizer is the large-cap pharma proxy traders default to on infectious-disease headlines.

MRNA: Moderna carries the highest headline beta among vaccine names.

Watch for unusual call flow only if the story escalates beyond monitoring. For more geopolitics coverage, see other market news here.

Want more market intelligence? Create your free Unusual Whales account for options flow, market tide, GEX, and the full toolkit.

Track PFE on Unusual Whales
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.